These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 23329572)

  • 1. Therapeutic outcomes of transplanting autologous granulocyte colony-stimulating factor-mobilised peripheral mononuclear cells in diabetic patients with critical limb ischaemia.
    Mohammadzadeh L; Samedanifard SH; Keshavarzi A; Alimoghaddam K; Larijani B; Ghavamzadeh A; Ahmadi AS; Shojaeifard A; Ostadali MR; Sharifi AM; Amini MR; Mahmoudian A; Fakhraei H; Aalaa M; Mohajeri-Tehrani MR
    Exp Clin Endocrinol Diabetes; 2013 Jan; 121(1):48-53. PubMed ID: 23329572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes.
    Huang P; Li S; Han M; Xiao Z; Yang R; Han ZC
    Diabetes Care; 2005 Sep; 28(9):2155-60. PubMed ID: 16123483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Outcomes of using autologous peripheral-blood stem cells in patients with chronic lower arterial insufficiency].
    Maksimov AV; Kiiasov AP; Plotnikov MV; Maianskaia SD; Shamsutdinova II; Gazizov IM; Mavlikeev MO
    Angiol Sosud Khir; 2011; 17(2):11-5. PubMed ID: 21983456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of autologous transplantation of G-CSF-mobilized peripheral blood mononuclear cells and Panax notoginseng saponins in the treatment of unreconstructable critical limb ischemia.
    Wang X; Jiang L; Wang X; Yin F; Li G; Feng X; Wang K; Sun S
    Ann Vasc Surg; 2014 Aug; 28(6):1501-12. PubMed ID: 24632316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study on autologous implantation between bone marrow stem cells and peripheral blood stem cells for treatment of lower limb ischemia].
    Gu Y; Zhang J; Qi L
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Jul; 21(7):675-8. PubMed ID: 17694651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral blood progenitor cell mobilization with intermediate-dose cyclophosphamide, sequential granulocyte-macrophage-colony-stimulating factor and granulocyte-colony-stimulating factor, and scheduled commencement of leukapheresis in 225 patients undergoing autologous transplantation.
    Bashey A; Donohue M; Liu L; Medina B; Corringham S; Ihasz A; Carrier E; Castro JE; Holman PR; Xu R; Law P; Ball ED; Lane TA
    Transfusion; 2007 Nov; 47(11):2153-60. PubMed ID: 17958545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem cell and progenitor cell therapy in peripheral artery disease. A critical appraisal.
    Lawall H; Bramlage P; Amann B
    Thromb Haemost; 2010 Apr; 103(4):696-709. PubMed ID: 20174766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A clinical study on implantation of autologous bone marrow mononuclear cells after bone marrow stimulation for treatment of lower limb ischemia].
    Gu Y; Zhang J; Qi L
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Oct; 20(10):1017-20. PubMed ID: 17140078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutical potential of autologous peripheral blood mononuclear cell transplantation in patients with type 2 diabetic critical limb ischemia.
    Ozturk A; Kucukardali Y; Tangi F; Erikci A; Uzun G; Bashekim C; Sen H; Terekeci H; Narin Y; Ozyurt M; Ozkan S; Sayan O; Rodop O; Nalbant S; Sıldıroglu O; Yalnız FF; Senkal IV; Sabuncu H; Oktenli C
    J Diabetes Complications; 2012; 26(1):29-33. PubMed ID: 22240264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte colony-stimulating factor improves the efficacy of autologous bone marrow-derived mononuclear cell transplantation treatment for lower limb ischemia.
    Gu Y; Guo L; Guo J; Dardik A; Zhang S; Tong Z; Zhang J; Wang Z
    Int Angiol; 2017 Aug; 36(4):346-353. PubMed ID: 27958690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local intramuscular transplantation of autologous mononuclear cells for critical lower limb ischaemia.
    Moazzami K; Moazzami B; Roohi A; Nedjat S; Dolmatova E
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD008347. PubMed ID: 25525690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Autologous bone-marrow stem-cell transplantation for induction of arteriogenesis for limb salvage in critical limb ischaemia].
    Amann B; Lüdemann C; Ratei R; Schmidt-Lucke JA
    Zentralbl Chir; 2009 Aug; 134(4):298-304. PubMed ID: 19688676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiographic demonstration of neoangiogenesis after intra-arterial infusion of autologous bone marrow mononuclear cells in diabetic patients with critical limb ischemia.
    Ruiz-Salmeron R; de la Cuesta-Diaz A; Constantino-Bermejo M; Pérez-Camacho I; Marcos-Sánchez F; Hmadcha A; Soria B
    Cell Transplant; 2011; 20(10):1629-39. PubMed ID: 22289660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond CD34+ cell dose: impact of method of peripheral blood hematopoietic stem cell mobilization (granulocyte-colony-stimulating factor [G-CSF], G-CSF plus plerixafor, or cyclophosphamide G-CSF/granulocyte-macrophage [GM]-CSF) on number of colony-forming unit-GM, engraftment, and Day +100 hematopoietic graft function.
    Alexander ET; Towery JA; Miller AN; Kramer C; Hogan KR; Squires JE; Stuart RK; Costa LJ
    Transfusion; 2011 Sep; 51(9):1995-2000. PubMed ID: 21392017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intramuscular transplantation of G-CSF-mobilized CD34(+) cells in patients with critical limb ischemia: a phase I/IIa, multicenter, single-blinded, dose-escalation clinical trial.
    Kawamoto A; Katayama M; Handa N; Kinoshita M; Takano H; Horii M; Sadamoto K; Yokoyama A; Yamanaka T; Onodera R; Kuroda A; Baba R; Kaneko Y; Tsukie T; Kurimoto Y; Okada Y; Kihara Y; Morioka S; Fukushima M; Asahara T
    Stem Cells; 2009 Nov; 27(11):2857-64. PubMed ID: 19711453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous transplantation of peripheral blood stem cells as an effective therapeutic approach for severe arteriosclerosis obliterans of lower extremities.
    Huang PP; Li SZ; Han MZ; Xiao ZJ; Yang RC; Qiu LG; Han ZC
    Thromb Haemost; 2004 Mar; 91(3):606-9. PubMed ID: 14983238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse events during treatment of critical limb ischemia with autologous peripheral blood mononuclear cell implant.
    Jonsson TB; Larzon T; Arfvidsson B; Tidefelt U; Axelsson CG; Jurstrand M; Norgren L
    Int Angiol; 2012 Feb; 31(1):77-84. PubMed ID: 22330628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial.
    Tateishi-Yuyama E; Matsubara H; Murohara T; Ikeda U; Shintani S; Masaki H; Amano K; Kishimoto Y; Yoshimoto K; Akashi H; Shimada K; Iwasaka T; Imaizumi T;
    Lancet; 2002 Aug; 360(9331):427-35. PubMed ID: 12241713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral blood stem cell mobilization by granulocyte colony-stimulating factor alone and engraftment kinetics following autologous transplantation in children and adolescents with solid tumor.
    Watanabe H; Watanabe T; Suzuya H; Wakata Y; Kaneko M; Onishi T; Okamoto Y; Abe T; Kawano Y; Kagami S; Takaue Y
    Bone Marrow Transplant; 2006 Apr; 37(7):661-8. PubMed ID: 16489358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.